Seroflo-125 Inhaler Fluticasone Propionate 125mcg,
Seroflo-125 Inhaler INH
Seroflo-125 Inhaler from Cipla contains Fluticasone + Salmeterol
Below are some of the details of Fluticasone + Salmeterol(generic)
The combination preparation fluticasone/salmeterol is a formulation containing fluticasone propionate and salmeterol xinafoate used in the management of asthma and chronic obstructive pulmonary disease (COPD). It is marketed by GlaxoSmithKline as ForAir (India). Annual sales approx $3.8B. Patent expires 2010.
Fluticasone, a corticosteroid, is the anti-inflammatory component of the combination, while salmeterol treats constriction of the airways. Together, they relieve the symptoms of coughing, wheezing and shortness of breath better than either fluticasone or salmeterol taken on its own.